{"nct_id":"NCT03615326","title":"Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2018-10-05","start_date_type":"ACTUAL","primary_completion_date":"2024-03-20","primary_completion_date_type":"ACTUAL","completion_date":"2025-11-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}